Beyond its direct impact on treating red blood cell disorders, the findings suggest that metabolic features such as glutamine–to–glutamate ratios can be used as biomarkers for many other diseases.

The 2024 ASH Annual Meeting showcased advancements in red blood cell disorders, including anemia, sickle cell disease, and thalassemia, with a focus on innovative treatments and emerging technologies.

Blood cell disorders refers to conditions that have adverse effects on the red and white blood cells and smaller circulating cells known as platelets. These three cell types develop in the bone ...

Red blood cells, long thought to be passive bystanders in the formation of blood clots, actually play an active role in ...

New gene therapy approach developed for red blood cell disorders Date: March 27, 2012 Source: NewYork-Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Summary ...

Blood stem cells develop through different stages to become fully mature red blood cells. This fundamental biologic process is defined by a series of complex metabolic processes, which are often ...

Researchers from the University of Pennsylvania found that red blood cells, not just platelets, actively contribute to the ...

Combining lasers with a principle discovered by Alexander Graham Bell over 100 years ago, researchers have developed a new way to collect high-resolution information about the shape of red blood ...

Researchers at Northwell’s Feinstein Institutes for Medical Research have received a $6 million grant from the National Institutes of Health to study red blood cell disorders, the health system ...

Sickle cell disease disproportionately affects people in the U.S. who are Black. Patient blood recipients finding a good match can mean everything.

"We found the gene is integrated into cells which have not yet begun to make red blood cells, and when they do, the beta-globin gene is activated," Dr. Rivella says.